Quote:

---

Wonder what the next surprise will be.

---

Here's just some of what's coming up...

Listing on to NASDAQ
MANF: File ODD for RP in Europe
MANF: Initiate GMP Manufacturing
MANF: Retinal Artery Occlusion Approval
Eltoprazine: IND submission
Eltoprazine: Initiate Phase 2b clinical trials
Lympro: First pharmaceutical biomarker customer sales
Lympro: Publish data
Lympro: CLIA Certification
Lympro: CE Mark
Lympro: FDA pathway evaluation
ESS: Close deal